Madrigal Pharmaceuticals Inc Financial Flexibility Index
Madrigal Pharmaceuticals Inc financial flexibility index. Madrigal Pharmaceuticals Inc (MDGL) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of $-133.07 Million (operating CF $-133.46 Million minus capex $390.00K) represents 0% of total liabilities ($656.90 Million). Explore capital reinvestment ratio of Madrigal Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Madrigal Pharmaceuticals Inc (2003–2025)
Financial flexibility index of Madrigal Pharmaceuticals Inc from 2003 to 2025. Historical Financial Flexibility Index trend for Madrigal Pharmaceuticals Inc across 23 annual periods. Check Madrigal Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Madrigal Pharmaceuticals Inc Financial Flexibility Index by Year (2003–2025)
Madrigal Pharmaceuticals Inc financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Madrigal Pharmaceuticals Inc. For the full cash flow conversion analysis, see Madrigal Pharmaceuticals Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.29x | $-189.09 Million | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-454.11 Million | $-455.57 Million | $287.86 Million | ▼ -15.0% |
| 2023 | -1.37x | $-322.75 Million | $-324.23 Million | $235.21 Million | ▼ -0.9% |
| 2022 | -1.36x | $-224.64 Million | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.71 Million | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.34x | $-157.23 Million | $-157.56 Million | $47.02 Million | ▼ -105.6% |
| 2019 | -1.63x | $-41.45 Million | $-41.62 Million | $25.49 Million | ▲ +46.1% |
| 2018 | -3.02x | $-25.48 Million | $-25.51 Million | $8.44 Million | ▼ -36.7% |
| 2017 | -2.21x | $-22.19 Million | $-22.32 Million | $10.05 Million | ▲ +39.8% |
| 2016 | -3.67x | $-17.60 Million | $-17.61 Million | $4.80 Million | ▲ +8.6% |
| 2015 | -4.01x | $-71.39 Million | $-71.44 Million | $17.79 Million | ▼ -81.0% |
| 2014 | -2.22x | $-78.78 Million | $-78.92 Million | $35.54 Million | ▼ -33.4% |
| 2013 | -1.66x | $-76.64 Million | $-77.41 Million | $46.11 Million | ▲ +13.4% |
| 2012 | -1.92x | $-53.63 Million | $-54.13 Million | $27.95 Million | ▼ -13.4% |
| 2011 | -1.69x | $-46.61 Million | $-47.30 Million | $27.55 Million | ▼ -36.0% |
| 2010 | -1.24x | $-38.06 Million | $-38.20 Million | $30.59 Million | ▼ -13.3% |
| 2009 | -1.10x | $-26.36 Million | $-26.81 Million | $24.00 Million | ▼ -379.3% |
| 2008 | -0.23x | $-35.76 Million | $-37.94 Million | $156.04 Million | ▼ -175.7% |
| 2007 | 0.30x | $29.57 Million | $27.22 Million | $97.75 Million | ▲ +133.3% |
| 2006 | -0.91x | $-51.41 Million | $-52.98 Million | $56.54 Million | ▲ +70.1% |
| 2005 | -3.04x | $-57.00 Million | $-61.88 Million | $18.73 Million | ▼ -32.9% |
| 2004 | -2.29x | $-32.20 Million | $-33.80 Million | $14.06 Million | ▲ +65.0% |
| 2003 | -6.53x | $-22.84 Million | $-23.61 Million | $3.50 Million | — |